Selected aspects of the aetiology, pathogenesis and treatment of disorders of purine metabolism.
D000493:Allopurinol / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D005953:Glycogen Storage Disease Type I / Q000150:complications; D006073:Gout / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology / Q000378:metabolism; D006801:Humans; D007926:Lesch-Nyhan Syndrome / Q000150:complications / Q000201:enzymology; D008661:Metabolism, Inborn Errors / Q000150:complications; D010430:Pentosyltransferases / Q000494:pharmacology; D011685:Purine Nucleotides / Q000096:biosynthesis; D011687:Purines / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism*; D014527:Uric Acid / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism* / Q000652:urine
D011685:Purine Nucleotides; D011687:Purines; D014527:Uric Acid; D000493:Allopurinol; D010430:Pentosyltransferases; D003078:Colchicine